Up-regulation of the gene encoding protein kinase A type Iα regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 2, 2006, Pages 563-568

  Hibi, Yatsuka ^a,c   Kambe, Fukushi ^a   Tominaga, Yoshihiro ^b   Mizuno, Yutaka ^c   Kobayashi, Hironobu ^c   Iwase, Katsumi ^d   Imai, Tsuneo ^c   Seo, Hisao ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN SUBUNIT; TYPE I ALPHA REGULATORY SUBUNIT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; NODULAR HYPERPLASIA; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PARATHYROID GLAND; PARATHYROID HYPERPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPERPARATHYROIDISM, SECONDARY; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; NUCLEIC ACID HYBRIDIZATION; PARATHYROID GLANDS; PROTEINS; RNA; UP-REGULATION;

EID: 32544444582     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-2155     Document Type: Article

References (37)

1. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443
2. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598-1606
3. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H 1997 Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13:78-86
4. Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H 1992 Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16:595-603
5. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drueke TB 1995 Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047-2053
6. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, Numano M, Tanaka Y, Takagi H 1996 Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 20:744-752
7. Fukagawa M, Okazaki R, Takano K, Kaname S, Ogata E, Kitaoka M, Harada S, Sekine N, Matsumoto T, Kurokawa K 1990 Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis. N Engl J Med 323:421-422
8. Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H 2002 Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism. Kidney Int 62:1196-1207
9. Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi ML 1993 Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76:139-144
10. 2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80:3107-3110
11. Brown SB, Brierley TT, Palanisamy N, Salusky IB, Goodman W, Brandi ML, Drueke TB, Sarfati E, Urena P, Chaganti RS, Pike JW, Arnold A 2000 Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia. J Clin Endocrinol Metab 85:868-872
12. Imanishi Y, Tahara H, Palanisamy N, Spitalny S, Salusky IB, Goodman W, Brandi ML, Drueke TB, Sarfati E, Urena P, Chaganti RS, Arnold A 2002 Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia. J Am Soc Nephrol 13:1490-1498
13. Cho-Chung YS 2004 Antisense protein kinase A RIα-induced tumor reversion: portrait of a microarray. Biochim Biophys Acta 1697:71-79
14. Clegg CH, Cadd GG, McKnight GS 1988 Genetic characterization of a brainspecific form of the type I regulatory subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci USA 85:3703-3707
15. Amieux PS, McKnight GS 2002 The essential role of RIα in the maintenance of regulated PKA activity. Ann NY Acad Sci 968:75-95
16. Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H 1995 Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 44:S42-S47
17. Sarkar D, Imai T, Kambe F, Shibata A, Ohmori S, Siddiq A, Hayasaka S, Funahashi H, Seo H 2001 The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisolproducing adrenocortical adenomas. J Clin Endocrinol Metab 86:5130-5137
18. Kambe F, Seo H, Murata Y, Matsui N 1988 Cloning of a complementary deoxyribonucleic acid coding for human thyroxine-binding globulin (TBG): existence of two TBG messenger ribonucleic acid species possessing different 3′-untranslated regions. Mol Endocrinol 2:181-185
19. Sakai T, Kambe F, Mitsuyama H, Ishiguro N, Kurokouchi K, Takigawa M, Iwata H, Seo H 2001 Tumor necrosis factor-induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-κB: abrogation of the tumor necrosis factor-α effect by proteasome inhibitors. J Bone Miner Res 16:1272-12780
20. Kemp BE, Graves DJ, Benjamini E, Krebs EG 1977 Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J Biol Chem 252:4888-4894
21. Hatefi Y 1985 The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54:1015-1069
22. Bossis I, Stratakis CA 2004 PRKAR1A: normal and abnormal functions. Endocrinology 145:5452-5458
23. Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS 2001 p21WAF1 and TGF-α mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 60:2109-2117
24. Cozzolino M, Dusso AS, Slatopolsky E 2001 Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 12:2511-2516
25. Dusso AS, Pavlopoulos T, Naumovich L, Lu Y, Finch J, Brown AJ, Morrissey J, Slatopolsky E 2001 p21WAF1 and transforming growth factor-α mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 59:855-865
26. Dusso A, Cozzolino M, Lu Y, Sato T, Slatopolsky E 2004 1,25-Dihydroxyvitamin D downregulation of TGFα/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. J Steroid Biochem Mol Biol 89-90:507-511
27. Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A 2005 Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol 18:5-8
28. 2+. J Biol Chem 273:15192-15202
29. Tortora G, Pepe S, Bianco C, Baldassarre G, Budillon A, Clair T, Cho-Chung YS, Bianco AR, Ciardiello F 1994 The RIα subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene 9:3233-3240
30. Tortora G, Pepe S, Bianco C, Damiano V, Ruggiero A, Baldassarre G, Corbo C, Cho-Chung YS, Bianco AR, Ciardiello F 1994 Differential effects of protein kinase A subunits on Chinese-hamster-ovary cell cycle and proliferation. Int J Cancer 59:712-716
31. Neary CL, Nesterova M, Cho YS, Cheadle C, Becker KG, Cho-Chung YS 2004 Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion. Oncogene 23:8847-8856
32. Yang WL, Iacono L, Tang WM,Chin KV 1998 Novel function of the regulatory subunit of protein kinase A: regulation of cytochrome c oxidase activity and cytochrome c release. Biochemistry 37:14175-14180
33. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA 2000 Mutations of the gene encoding the protein kinase A type Iα regulatory subunit in patients with the Carney complex. Nat Genet 26:89-92
34. Griffin KJ, Kirschner LS, Matyakhina L, Stergiopoulos S, Robinson-White A, Lenherr S, Weinberg FD, Claflin E, Meoli E, Cho-Chung YS, Stratakis CA 2004 Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res 64:8811-8815
35. Amieux PS, Cummings DE, Motamed K, Brandon EP, Wailes LA, Le K, Idzerda RL, McKnight GS 1997 Compensatory regulation of RIprotein levels in protein kinase A mutant mice. J Biol Chem 272:3993-3998
36. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS 1996 Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A. Nature 382:622-6226
37. Noguchi K, Murata T, Cho-Chung YS 1998 8-chloroadenosine 3′,5′-monophosphate (8-Cl-cAMP) selectively eliminates protein kinaseAtype I to induce growth inhibition in c-ras-transformed fibroblasts. Eur J Cancer 34:1260-1267